Patents by Inventor Chandra Sekhar Kurova

Chandra Sekhar Kurova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug Targets of Delayed Aging and Human Brain Diseases
    Publication number: 20210196732
    Abstract: The present invention includes a molecule and method of identifying and a method of using the molecule to inhibit the interaction of A? and Drp1 proteins, including diethyl(3,4-dihydroxyphenethylamine)(quinolin-4-yl)methylphosphonate (DDQ); phosphonium,[10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl]triphenyl-, methanesulfonate) (MitoQ); (3-Hydroxy-naphthalene-2-carboxylic acid (3,4-dihydroxy-benzylidene)-hydrazide (Dynasore); and/or (3-(2,4-Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone, or derivatives thereof.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 1, 2021
    Inventors: Hemachandra Reddy, Chandra Sekhar Kurova
  • Drug targets of delayed aging and human brain diseases
    Patent number: 10987367
    Abstract: The present invention includes a molecule, a method of identifying said molecule, and a method of using said molecule to inhibit the interaction of A? and Drp1 proteins. The molecules including diethyl (3,4-dihydroxyphenethylamine)(quinolin-4-yl)methylphosphonate (DDQ); [10-(4,5-dimethoxy2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl]triphenylphosphonium methanesulfonate (MitoQ); 3-Hydroxynaphthalene-2-carboxylic acid (3,4-dihydroxy-benzylidene)-hydrazide (Dynasore); and/or 3-(2,4Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone/3-(2,4-Dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone (Mdivi-1).
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: April 27, 2021
    Assignee: Texas Tech University System
    Inventors: Hemachandra Reddy, Chandra Sekhar Kurova
  • Drug Targets of Delayed Aging and Human Brain Diseases
    Publication number: 20190374558
    Abstract: The present invention includes a molecule, a method of identifying said molecule, and a method of using said molecule to inhibit the interaction of A? and Drp1 proteins. The molecules including diethyl (3,4-dihydroxyphenethylamine)(quino-lin-4-yl)methylphosphonate (DDQ); [10-(4,5-dimethoxy2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl]triphenylphosphonium methanesulfonate (MitoQ); 3-Hydroxynaphthalene-2-carboxylic acid (3,4-dihydroxy-benzylidene)-hydrazide (Dynasore); and/or 3-(2,4Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone/3-(2,4-Dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone (Mdivi-1).
    Type: Application
    Filed: November 28, 2017
    Publication date: December 12, 2019
    Inventors: Hemachandra Reddy, Chandra Sekhar Kurova